Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

RMJ. 2013; 38(3): 215-218


Assessment of platelets count and coagulation parameters among Sudanese patients with liver cirrhosis

Tagwa Yousif Elsayed, Fathelrahman Mahdi Hassan.




Abstract

Background: Coagulation abnormalities in patients with liver cirrhosis were occurred from impairments in the clotting and fibrinolytic systems, as well as from reduced number and function of platelets. This study was carried out to assess the haemostatic defects in patients of liver cirrhosis by estimating prothrombin time (PT), activated partial thromboplastin time (APTT), plasma fibrinogen level, fibrinogen degradation products (D-dimer), and platelet count.
Materials and Methods: This was a prospective observational study; it was carried out in Ibn-Sina hospital-Khartoum State. A total of 50 patients with cirrhosis of liver were selected from all age groups of both gender and 50 normal healthy individuals without liver disease or any disease affected the haemostatic mechanism were selected as control group. All the investigations were carried out in patients by standard procedures.
Results: The mean value of platelets count in patients with cirrhosis and controls group was 119000 ± 63000 and 220000± 40000 cells/ ul respectively, which was significantly lower in cirrhotic patients than the normal range of 150,000 - 4000,000 cell/ ul (p=0.04).
The mean value of PT was 27.82 ± 15.9 and 13.58 ± 0.57 seconds in patients with liver cirrhosis and control group respectively and the prolongation in cirrhotic patients was highly significant statistically (p

Key words: Liver cirrhosis, coagulation defect, Fibrinogen, thrombocytopenia.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.